B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by Erythropoietin

REACTOME PATHWAY
Reactome: R-HSA-90063359 genes32 compounds

The Signaling by Erythropoietin pathway (Reactome ID: R-HSA-9006335) involves 9 genes and is affected by 32 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

GRB2JAK2LYNPIK3CBPIK3CDPIK3CGPIK3R1PIK3R5STAT5A

Compounds Affecting Signaling by Erythropoietin

#CompoundTargets HitStudies
1ly29400211
2pictilisib25
3Wortmannin300
4Sirolimus300
5alpelisib227
6torin 110
7Dasatinib299
8Quercetin300
9Sorafenib300
10Azauridine300
11Cladribine297
12Methylene Blue200
132-Methoxyestradiol300
14Astemizole Antihistamine drug now withdrawn from280
15Azathioprine300
16Calcitriol300
17Camptothecin300
18Cytarabine297
19dihydrorotenone13
20Podophyllotoxin14
21streptonigrin299
22Trifluridine295
23Tripterygium300
24myricetin-3-O-galactopyranoside [Supplementary Concept]300
25Ku 0063794 [Supplementary Concept]7
26tyrphostin ag 14784
27alsterpaullone12
28Crizotinib298
29kenpaullone8
30sp600125117
31Resveratrol298
32Dactinomycin297

About the Signaling by Erythropoietin Pathway

The Signaling by Erythropoietin pathway is catalogued in Reactome (ID: R-HSA-9006335) and involves 9 genes. In the BiohacksAI corpus, 32 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include GRB2, JAK2, LYN, PIK3CB, PIK3CD.